Study of Efficacy & Safety of Canakinumab in Pediatric Patients With

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05911386` - Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases
Recruiting	`NCT02951234` - A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease	N/A
Active, not recruiting	`NCT02853266` - Measurement of Antibodies in Adults With a History of Kawasaki Disease	N/A
Active, not recruiting	`NCT04747847` - Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease	Early Phase 1
Withdrawn	`NCT04535518` - Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease	Phase 3
Recruiting	`NCT01917721` - Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease	Phase 2
Recruiting	`NCT04656184` - A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment	Phase 3
Recruiting	`NCT03200561` - A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)	Phase 3
Completed	`NCT01440075` - Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease	N/A
Completed	`NCT02179853` - Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease	Phase 1/Phase 2
Enrolling by invitation	`NCT02359643` - Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease	N/A
Recruiting	`NCT04278404` - Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Completed	`NCT00760435` - Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease	Phase 3
Completed	`NCT00841789` - A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease	Phase 2
Not yet recruiting	`NCT05643651` - Rivaroxaban for Children With Giant Coronary Artery Aneurysms After Kawasaki Disease	Phase 4
Recruiting	`NCT02114099` - Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease	Phase 2
Not yet recruiting	`NCT05091229` - A Blood Test to Diagnose Kawasaki Disease
Completed	`NCT01431105` - Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities	Phase 1/Phase 2
Recruiting	`NCT01793168` - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Recruiting	`NCT06305611` - European and North Indian Cohort of KaWasaki dIsease

NCT number	NCT02980263
Study type	Interventional
Source	Novartis
Contact
Status	Withdrawn
Phase	Phase 2
Start date	November 15, 2016
Completion date	November 30, 2017

Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms